Literature DB >> 26398208

Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?

Adam C Yopp1, Michael A Choti.   

Abstract

Within developed countries the incidence of hepatocellular carcinoma (HCC) has been progressively increasing despite diagnosing fewer new cases of cirrhosis linked to viral hepatitis and alcohol consumption. This increased incidence parallels the epidemic of morbid obesity and metabolic syndrome and may be secondary to non-alcoholic steatohepatitis (NASH)-related HCC. The aims of this chapter are to (1) define the natural history of non-alcoholic fatty liver disease/NASH, (2) discuss the relationship between cryptogenic cirrhosis and NASH-related cirrhosis, (3) compare the presentation and treatment of NASH-related HCC to viral hepatitis-related cirrhosis and (4) identify the genetic factors associated with NASH and NASH-related HCC.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26398208     DOI: 10.1159/000438473

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  9 in total

1.  Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma.

Authors:  Jessie Torgersen; Tamar H Taddei; Lesley S Park; Dena M Carbonari; Michael J Kallan; Kisha Mitchell Richards; Xuchen Zhang; Darshana Jhala; Norbert Bräu; Robert Homer; Kathryn D'Addeo; Rajni Mehta; Melissa Skanderson; Farah Kidwai-Khan; Amy C Justice; Vincent Lo Re
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-01       Impact factor: 4.254

2.  Therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced fatty liver disease, fibrosis and inflammation in rabbit.

Authors:  Pao-Yuan Lin; Chih-Hung Chen; Christopher Glenn Wallace; Kuan-Hung Chen; Chia-Lo Chang; Hong-Hwa Chen; Pei-Hsun Sung; Kun-Chen Lin; Sheung-Fat Ko; Cheuk-Kwan Sun; Hsueh-Wen Chang; Pei-Lin Shao; Mel S Lee; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 3.  Diagnosis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Hannele Yki-Järvinen
Journal:  Diabetologia       Date:  2016-04-18       Impact factor: 10.122

Review 4.  Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.

Authors:  Gonzalo Sapisochin; Jordi Bruix
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

5.  Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma.

Authors:  Dai Liu; Kevin F Staveley-O'Carroll; Guangfu Li
Journal:  J Clin Cell Immunol       Date:  2015-12-10

Review 6.  Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.

Authors:  George Cholankeril; Ronak Patel; Sandeep Khurana; Sanjaya K Satapathy
Journal:  World J Hepatol       Date:  2017-04-18

Review 7.  Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma.

Authors:  Ozlem Kutlu; Humeyra Nur Kaleli; Ebru Ozer
Journal:  Can J Gastroenterol Hepatol       Date:  2018-08-29

8.  Image-guided chemistry altering biology: An in vivo study of thermoembolization.

Authors:  Erik N K Cressman; Chunxiao Guo; Niloofar Karbasian
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

9.  Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma.

Authors:  Sana Raza; Sangam Rajak; Baby Anjum; Rohit A Sinha
Journal:  Hepatoma Res       Date:  2019-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.